Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapies

Overall survival of patients with hepatocellular carcinoma (HCC) refractory to locoregional therapy is dismal, even following treatment with sorafenib, a multikinase inhibitor. To develop a more efficacious treatment, we undertook a feasibility study of personalized peptide vaccination (PPV) for HCC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Yutani, Shigeru, Shirahama, Takahisa, Muroya, Daisuke, Matsueda, Satoko, Yamaguchi, Rin, Morita, Michi, Shichijo, Shigeki, Yamada, Akira, Sasada, Tetsuro, Itoh, Kyogo
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5581512/
https://ncbi.nlm.nih.gov/pubmed/28622427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13301
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados